Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancer Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyond Tarlatamab achieves 40% overall response rate at the dose selected for continued evaluation Oct 22, 2023
Suzanne Somers' Legacy Tainted by Celebrity Medical Misinformation The actress harnessed the power of traditional media like social media influencers do today Oct 22, 2023
Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer Durvalumab plus olaparib, or alone, paired with chemo boosts PFS in DUO-E trial Oct 21, 2023
Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Years And early ctDNA reductions correlated with survival Oct 21, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancer But label update planned after potential harm observed in PD-L1-negative subgroup Oct 20, 2023
Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd Oct 19, 2023
Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatment News, features, and commentary about cancer-related issues Oct 19, 2023
Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A "Strategy will probably be practice-changing," says expert Oct 18, 2023
Senators Grill NIH Director Nominee on Drug Prices, Gender-Affirming Care Monica Bertagnolli, MD, makes her case during confirmation hearing Oct 18, 2023
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train? It's time for clear guidelines Oct 18, 2023
What Caused the Pigmented Spot on Teen Boy's Eye? Authors discuss how best to diagnose and manage him, given the absence of any symptoms Oct 17, 2023
Pembrolizumab Wins FDA Approval in Operable Lung Cancer Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting Oct 17, 2023
Hemoglobin Targets a Good Idea for Massively Transfused Patients Outcomes improved with values approaching 10 g/dL Oct 16, 2023
Suzanne Somers Dies; FDA Plans to Ban Hair Relaxers; Health Worker Minimum Wage Health news and commentary from around the Web gathered by 鶹ý staff Oct 16, 2023
Study Validates Accuracy of PREDICT Prognostication Tool in Breast Cancer Findings suggest it's a suitable decision aid for U.S. oncologists and patients Oct 13, 2023
Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomes The first randomized trials of both approaches failed Oct 13, 2023
Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout? News, features, and commentary about cancer-related issues Oct 13, 2023
New Lung Cancer Cases Are Higher in Younger Women vs Men And the higher incidence rates now extend to women ages 50 to 54 as well Oct 12, 2023
Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLC Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients Oct 12, 2023
'Abortion Test' Sparks Concern; AI in Brain Surgery; 'Is There a Doctor on Board?' Health news and commentary from around the Web gathered by 鶹ý staff Oct 12, 2023
Rare Lung Bleeds Cluster in DOAC Users, Implications Unclear Pattern found in diffuse alveolar hemorrhage reports in FAERS Oct 11, 2023
Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancer Durable responses across all three major subtypes of breast cancer Oct 10, 2023
How a Multi-Cancer Screening Test Would Play Out in the Clinic True positives identified with Grail's assay typically confirmed in under 2 months Oct 10, 2023
Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Live News, features, and commentary about cancer-related issues Oct 06, 2023
Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBC Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panel But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? Detectable circulating tumor DNA before radiotherapy linked with worse survival Oct 05, 2023
FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remission Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Time Time to treatment completion slashed by over 4 hours compared with CT simulation planning Oct 04, 2023
Drugmaker Plans to Pull Lung Cancer Therapy From the Market Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survival PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kids Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
FDA Greenlights Test for Cancer-Predisposing Genetic Mutations First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatment Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
